Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse

被引:24
|
作者
Anderson, Karen L. [1 ]
Itzhak, Yossef [1 ]
机构
[1] Univ Miami, Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA
关键词
methamphetamine; dopamine; serotonin; neurotoxicity; nitric oxide (NO); nitrate; nitrite; peroxynitrite;
D O I
10.1196/annals.1369.021
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Exposure to high doses of methamphetamine (METH), a major drug of abuse, may cause neuronal damage. Previous studies have implicated the role of peroxynitrite, produced by nitric oxide (NO) and reactive oxygen species, in dopaminergic neurotoxicity produced by METH in mice. The present article was undertaken to investigate if a neurotoxic regimen of METH is associated with changes in tissue levels of nitrate and nitrite, which are the stable products of NO. Administration of METH (5 mg/kg x 3) to Swiss Webster mice resulted in marked depletion of dopamine (DA) and DA transporter (DAT) binding sites but no change in 5-hydroxytryptamine (5-HT) and 5-HT transporter (5-HTT) binding sites in the striatum, amygdala, frontal cortex, and hippocampus, suggesting that METH causes selective neurotoxicity to DA nerve terminals. The concentration of nitrate in the striatum was increased by about twofold after METH administration; however, no changes in nitrate concentration were detected in other brain regions that endured dopaminergic neurotoxicity. These findings suggest that (a) a neurotoxic regimen of METH produces selective increase in NO in the striatum, which may generate toxic species such as peroxynitrite, and (b) toxins other than NO-related derivatives may mediate dopaminergic neurotoxicity in the amygdala and frontal cortex.
引用
收藏
页码:225 / 233
页数:9
相关论文
共 50 条
  • [1] Baicalein reverses the methamphetamine-induced striatal dopaminergic neurotoxicity in mice
    Liu, Yen-Yin
    Yeh, Pen-Ho
    Wang, Guei-Jane
    Huang, Seng-Wong
    Chi, Chin-Wen
    Ho, Li-Kang
    Pan, Wynn H. T.
    JOURNAL OF FOOD AND DRUG ANALYSIS, 2006, 14 (04) : 317 - 322
  • [2] Baicalein reverses the methamphetamine-induced striatal dopaminergic neurotoxicity in mice
    Liu, Yen-Yin
    Chi, Chin-Wen
    Ho, Li-Kang
    Pan, Wynn H. T.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 335 - 335
  • [3] Markers associated with testosterone enhancement of methamphetamine-induced striatal dopaminergic neurotoxicity
    Buletko, A. Blake
    Dluzen, Dean E.
    McDermott, Janet L.
    Darvesh, Altaf S.
    Geldenhuys, Werner J.
    NEUROTOXICOLOGY AND TERATOLOGY, 2012, 34 (03) : 336 - 341
  • [4] Mechanisms of methamphetamine-induced dopaminergic neurotoxicity
    Evan L. Riddle
    Annette E. Fleckenstein
    Glen R. Hanson
    The AAPS Journal, 2006, 8
  • [5] Mechanisms of methamphetamine-induced dopaminergic neurotoxicity
    Riddle, Evan L.
    Fleckenstein, Annette E.
    Hanson, Glen R.
    AAPS JOURNAL, 2006, 8 (02): : E413 - E418
  • [6] RELATIONSHIPS AMONG GENDER, AGE, TIME, AND TEMPERATURE IN METHAMPHETAMINE-INDUCED STRIATAL DOPAMINERGIC NEUROTOXICITY
    Dluzen, D. E.
    McDermott, J. L.
    Darvesh, A. S.
    NEUROSCIENCE, 2010, 167 (04) : 985 - 993
  • [7] Parity decreases methamphetamine-induced striatal dopaminergic perturbation
    Dluzen, Dean E.
    NEUROCHEMISTRY INTERNATIONAL, 2011, 59 (02) : 101 - 103
  • [8] Role of peroxynitrite in methamphetamine-induced dopaminergic neurotoxicity and sensitization in mice
    Ali, SF
    Haung, P
    Itzhak, Y
    ADDICTION BIOLOGY, 2000, 5 (03) : 331 - 341
  • [9] Local proteins associated with methamphetamine-induced nigrostriatal dopaminergic neurotoxicity
    Liao, PC
    Kuo, YM
    Hsu, HC
    Cherng, CG
    Yu, L
    JOURNAL OF NEUROCHEMISTRY, 2005, 95 (01) : 160 - 168
  • [10] Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson’s disease
    Eun-Joo Shin
    Ji Hoon Jeong
    Yeonggwang Hwang
    Naveen Sharma
    Duy-Khanh Dang
    Bao-Trong Nguyen
    Seung-Yeol Nah
    Choon-Gon Jang
    Guoying Bing
    Toshitaka Nabeshima
    Hyoung-Chun Kim
    Archives of Pharmacal Research, 2021, 44 : 668 - 688